UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How I treat thalassemia

Blood, 2011-09, Vol.118 (13), p.3479-3488

2011

Volltextzugriff (PDF)

Bone loss caused by iron overload in a murine model: importance of oxidative stress

Blood, 2010-10, Vol.116 (14), p.2582-2589

2010

Volltextzugriff (PDF)

Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients

PloS one, 2012-03, Vol.7 (3), p.e32345-e32345

2012

Volltextzugriff (PDF)

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia

Nature medicine, 2013-04, Vol.19 (4), p.437-445

2013

Volltextzugriff (PDF)

Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)

Transfusion (Philadelphia, Pa.), 2014-04, Vol.54 (4), p.972-981

2014

Volltextzugriff (PDF)

An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres

British journal of haematology, 2022-01, Vol.196 (2), p.380-389

2022

Volltextzugriff (PDF)

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice

The Journal of clinical investigation, 2010-12, Vol.120 (12), p.4466-4477

2010

Volltextzugriff (PDF)

Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

Journal of bone and mineral research, 2009-03, Vol.24 (3), p.543-557

2009

Volltextzugriff (PDF)

Combined iron chelation therapy

Annals of the New York Academy of Sciences, 2010-08, Vol.1202 (1), p.79-86

2010

Volltextzugriff (PDF)

The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores

Blood, 2010-07, Vol.116 (4), p.537-543

2010

Volltextzugriff (PDF)

Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea

PloS one, 2013-02, Vol.8 (2), p.e55709-e55709

2013

Volltextzugriff (PDF)

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

Blood, 2007-06, Vol.109 (11), p.5027-5035

2007

Volltextzugriff (PDF)

Epidemiologic and clinical characteristics of nontransfusion‐dependent thalassemia in the United States

Pediatric blood & cancer, 2018-07, Vol.65 (7), p.e27067-n/a

2018

Volltextzugriff (PDF)

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine

Haematologica (Roma), 2013-01, Vol.98 (1), p.129-135

2013

Volltextzugriff (PDF)

Renal dysfunction in patients with thalassaemia

British journal of haematology, 2011-04, Vol.153 (1), p.111-117

2011

Volltextzugriff (PDF)

Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America

British journal of haematology, 2009-09, Vol.146 (5), p.546-556

2009

Volltextzugriff (PDF)

Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort

Blood, 2012-03, Vol.119 (12), p.2746-2753

2012

Volltextzugriff (PDF)

Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia

Blood, 2008-08, Vol.112 (3), p.875-885

2008

Volltextzugriff (PDF)

Late complications of mixed chimerism following allogeneic bone marrow transplantation for thalassemia major

Pediatric blood & cancer, 2015-07, Vol.62 (7), p.1303-1304

2015

Volltextzugriff (PDF)

Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease

Pediatric blood & cancer, 2013-04, Vol.60 (4), p.653-658

2013

Volltextzugriff (PDF)

The palatability and tolerability of deferasirox taken with different beverages or foods

Pediatric blood & cancer, 2013-09, Vol.60 (9), p.1507-1512

2013

Volltextzugriff (PDF)

Iron chelation adherence to deferoxamine and deferasirox in thalassemia

American journal of hematology, 2011-05, Vol.86 (5), p.433-436

2011

Volltextzugriff (PDF)

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

The Lancet (British edition), 2003-05, Vol.361 (9369), p.1597-1602

2003

Volltextzugriff (PDF)

1 – 25 von 227

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(103)
Science & Technology
(97)
Life Sciences & Biomedicine
(92)
Female
(67)
Hematology
(66)
Male
(65)
Adult
(59)
Biological And Medical Sciences
(51)
Adolescent
(48)
Medical Sciences
(47)
Hematologic And Hematopoietic Diseases
(43)
Child
(42)
Anemias. Hemoglobinopathies
(40)
Diseases Of Red Blood Cells
(40)
Middle Aged
(32)
Thalassemia
(29)
Child, Preschool
(25)
Young Adult
(23)
Beta-Thalassemia - Therapy
(19)
Thalassemia - Therapy
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

How I treat thalassemia

Bone loss caused by iron overload in a murine model: importance of oxidative stress

Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia

Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)

An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice

Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)

A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD)

Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

Combined iron chelation therapy

The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores

Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

Epidemiologic and clinical characteristics of nontransfusion‐dependent thalassemia in the United States

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine

Renal dysfunction in patients with thalassaemia

Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America

Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort

Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia

Late complications of mixed chimerism following allogeneic bone marrow transplantation for thalassemia major

Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease

The palatability and tolerability of deferasirox taken with different beverages or foods

Iron chelation adherence to deferoxamine and deferasirox in thalassemia

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

Aktive Filter

Suchergebnisse filtern